Elevated platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with polymyositis/dermatomyositis: a retrospective study
- PMID: 36781682
- DOI: 10.1007/s10067-023-06542-7
Elevated platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with polymyositis/dermatomyositis: a retrospective study
Abstract
Objectives: This study aimed to examine the diagnostic and prognostic value of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) in patients with polymyositis/dermatomyositis (PM/DM).
Method: Clinical data of 200 patients with PM/DM and 204 healthy controls were retrospectively reviewed. We examined whether the PLR and NLR were associated with PM/DM.
Results: The PLR and NLR were higher in patients with PM/DM than in controls (both P < 0.001). The PLR and NLR were higher in patients with DM than in those with PM (both P < 0.01). The PLR was higher in the anti-melanoma differentiation-associated protein-5 (anti-MDA5) + PM/DM group than in the anti-MDA5- PM/DM group (P = 0.002). The NLR in non-survivors was higher than that in survivors (P = 0.01). The NLR was positively correlated with the occurrence of interstitial lung disease (ILD). The PLR and NLR were independent predictors of PM/DM, as well as risk factors (both P < 0.001). Moreover, the NLR had a predictive value for PM/DM-ILD and was closely related to mortality (P = 0.033, P = 0.003, respectively).
Conclusions: Patients with PM/DM have a higher NLR and PLR than healthy controls, especially in those with anti-MDA5+. The PLR and NLR are independent risk factors for PM/DM and have some predictive value. The NLR is correlated with ILD and associated with an increased risk of mortality in patients with PM/DM. The NLR and PLR may be simple, economical, and accurate diagnostic and prognostic markers for patients with PM/DM. Key points • The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been studied in numerous inflammatory diseases as potential markers, but their clinical significance in polymyositis/dermatomyositis (PM/DM) remains unclear. • We examined the changes in the NLR and PLR between patients with PM/DM and healthy controls, as well as their association with mortality, interstitial lung disease, and anti-melanoma differentiation-associated protein-5. • Patients with PM/DM may benefit from using the NLR and PLR as simple, economical, and accurate diagnostic and prognostic markers.
Keywords: Anti-melanoma differentiation-associated protein-5; Dermatomyositis; Interstitial lung disease; Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Polymyositis.
© 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).
Similar articles
-
Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are 2 new inflammatory markers associated with pulmonary involvement and disease activity in patients with dermatomyositis.Clin Chim Acta. 2017 Feb;465:11-16. doi: 10.1016/j.cca.2016.12.007. Epub 2016 Dec 10. Clin Chim Acta. 2017. PMID: 27965019
-
Inflammatory biomarkers in polymyositis/dermatomyositis patients with interstitial lung disease: a retrospective study.Curr Med Res Opin. 2024 Jan;40(1):113-122. doi: 10.1080/03007995.2023.2281501. Epub 2024 Jan 3. Curr Med Res Opin. 2024. PMID: 37938089
-
Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.Respir Med. 2016 Dec;121:91-99. doi: 10.1016/j.rmed.2016.10.019. Epub 2016 Nov 2. Respir Med. 2016. PMID: 27888997
-
Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020.Semin Arthritis Rheum. 2021 Feb;51(1):175-191. doi: 10.1016/j.semarthrit.2020.11.009. Epub 2020 Dec 29. Semin Arthritis Rheum. 2021. PMID: 33383294 Review.
-
Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.PLoS One. 2016 May 12;11(5):e0155381. doi: 10.1371/journal.pone.0155381. eCollection 2016. PLoS One. 2016. PMID: 27171228 Free PMC article. Review.
Cited by
-
Predictors of rapidly progressive interstitial lung disease and prognosis in Chinese patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis.Front Immunol. 2023 Aug 24;14:1209282. doi: 10.3389/fimmu.2023.1209282. eCollection 2023. Front Immunol. 2023. PMID: 37691917 Free PMC article.
-
Dermatomyositis: Practical Guidance and Unmet Needs.Immuno_targets Ther. 2024 Mar 6;13:151-172. doi: 10.2147/ITT.S381472. eCollection 2024. Immuno_targets Ther. 2024. PMID: 38464459 Free PMC article. Review.
-
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress.Nat Rev Rheumatol. 2024 Jan;20(1):48-62. doi: 10.1038/s41584-023-01054-9. Epub 2023 Dec 6. Nat Rev Rheumatol. 2024. PMID: 38057474 Review.
-
Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.Front Immunol. 2024 Apr 30;15:1404828. doi: 10.3389/fimmu.2024.1404828. eCollection 2024. Front Immunol. 2024. PMID: 38745647 Free PMC article.
-
The clinical value of KL-6 for predicting the occurrence and severity of connective tissue disease-associated interstitial lung disease is not affected by CTD type or treatment.PeerJ. 2024 Aug 8;12:e17792. doi: 10.7717/peerj.17792. eCollection 2024. PeerJ. 2024. PMID: 39131623 Free PMC article.
References
-
- Lundberg IE, Fujimoto M, Vencovsky J et al (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 7(1):86. https://doi.org/10.1038/s41572-021-00321-x - DOI - PubMed
-
- Gono T, Masui K, Nishina N et al (2021) Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis/dermatomyositis-associated interstitial lung disease. Arthritis Rheumatol 73(4):677–686. https://doi.org/10.1002/art.41566 - DOI - PubMed
-
- Marie I (2012) Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 14(3):275–285. https://doi.org/10.1007/s11926-012-0249-3 - DOI - PubMed
-
- Yang X, Hao Y, Zhang X et al (2020) Mortality of Chinese patients with polymyositis and dermatomyositis. Clin Rheumatol 39(5):1569–1579. https://doi.org/10.1007/s10067-019-04910-w - DOI - PubMed
-
- Fathi M, Dastmalchi M, Rasmussen E et al (2004) Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 63(3):297–301. https://doi.org/10.1136/ard.2003.006122 - DOI - PubMed - PMC
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical